#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14586	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2188	664.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1704	1704	T	829	T,C	735,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14586	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2188	664.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1438	1438	C	855	C	792	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27304	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3546	767.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1721	1721	A	920	A,G	827,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27304	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3546	767.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2355	2355	C	913	C	815	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27304	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3546	767.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2429	2429	A	883	A	810	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27304	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3546	767.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2981	2981	C	824	C	762	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	14	blaTEM	861	164	100.0	blaTEM.l15.c30.ctg.1	335	2.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	2128	folP	855	855	99.88	folP.l6.c4.ctg.1	1379	153.5	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	946	948	AGC	219;218;218	A;G;C	195;194;194	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5602	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3313	168.6	0	.	p	.	0	G95A	NONSYN	283	285	GGC	521	523	GCC	175;176;179	G,A;C,G;C	159,1;161,1;165	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5602	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3313	168.6	1	SNP	p	S91F	1	.	.	271	273	TTC	509	511	TTC	170;170;173	T;T;C	158;158;162	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1628	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1146	141.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	356	358	ACC	193;193;195	A,G;C;C	173,1;175;174	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1628	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1146	141.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	554	556	CAC	201;197;199	C;A;C	186;183;186	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1628	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1146	141.2	0	.	p	.	0	A127fs	FSHIFT	379	379	G	620	620	G	213	G	194	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1628	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1146	141.2	1	SNP	p	G45D	0	.	.	133	135	GGC	374	376	GGC	206;204;205	G;G,A;C	184;182,1;184	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	904	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	889	101.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4866	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3081	157.5	0	.	p	.	0	S87N	NONSYN	259	261	AGT	707	709	AAT	199;201;201	A;A;T	183;183;183	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4866	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3081	157.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1751	1753	GCA	212;210;209	G;C,T;A,G,T	189;181,1;174,1,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4866	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3081	157.5	1	SNP	p	D86N	0	.	.	256	258	GAC	704	706	GAC	203;204;203	G;A;C	183;182;186	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4866	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3081	157.5	1	SNP	p	S88P	0	.	.	262	264	TCC	710	712	TCC	204;205;207	T;C;C	184;185;188	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4292	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2612	163.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1454	1456	GGC	224;225;224	G;G;C	209;210;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2257	182.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1160	1162	GCA	236;238;239	G;C;A	204;206;209	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2257	182.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1163	1165	ATC	245;243;242	A;T;C	212;211;211	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2257	182.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1175	1177	GTG	244;242;241	G;T;G	214;211;210	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2257	182.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1175	1177	GTG	244;242;241	G;T;G	214;211;210	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2257	182.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1679	1681	ACC	197;193;192	A;C;C	173;171;172	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2257	182.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1733	1735	GCG	198;201;201	G;C;G	166;160;163	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2257	182.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1733	1735	GCG	198;201;201	G;C;G	166;160;163	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2257	182.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1856	1858	AGC	193;193;194	A;G;C	175;176;177	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2257	182.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1865	1867	GGC	190;189;187	G;G;C	170;172;169	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2257	182.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1883	1885	CCG	170;173;172	C,CG;C,G;GCCC,GGCCCC	101,1;109,1;97,3	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5950	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2971	199.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1542	1544	CCG	223;224;225	C;C;G	189;199;194	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2224	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1741	126.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	594	594	C	164	C	143	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3072	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1518	201.2	0	.	p	.	0	R143G	NONSYN	427	429	AGA	764	766	GGA	259;256;255	G,A;G,A;A	230,1;229,1;229	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3072	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1518	201.2	0	.	p	.	0	.	INDELS	629	630	AA	967	969	TAG	230;230;230	T;A;G	213;214;213	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3072	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1518	201.2	0	.	p	.	0	.	MULTIPLE	631	633	TAC	971	974	CAAT	231;232;233;230	C;A;A;T	213;217;218;217	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3072	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1518	201.2	0	.	p	.	0	N212fs	FSHIFT	634	634	A	976	976	T	229	T	216	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3072	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1518	201.2	1	SNP	p	G120K	0	.	.	358	360	GGT	695	697	GGT	264;262;264	G;G;T	245;243;238	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3072	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1518	201.2	1	SNP	p	A121D	0	.	.	361	363	GCC	698	700	GCC	264;265;266	G;C;C	241;245;245	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3072	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1518	201.2	1	SNP	p	A121N	0	.	.	361	363	GCC	698	700	GCC	264;265;266	G;C;C	241;245;245	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11218	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4752	235.5	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1949	1951	AAT	221;222;220	A;A;T	199;199;197	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1280	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	834	150.8	1	SNP	p	V57M	1	.	.	169	171	ATG	421	423	ATG	282;280;283	A;T;G	260;258;263	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	M177T	NONSYN	529	531	ATG	847	849	ACG	404;398;396	A;C;G	385;380;376	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	868	870	GAC	350;348;348	G;A;C	348;341;346	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	T190M	NONSYN	568	570	ACG	886	888	ATG	319;316;311	A;T;G	319;314;310	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	L194S	NONSYN	580	582	TTA	898	900	TCA	302;298;295	T;C,G;A	301;295,1;294	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	943	945	CAG	311;312;311	C;A;G	306;308;307	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	V216L	NONSYN	646	648	GTT	964	966	CTT	310;306;306	C,A;T;T	303,1;302;302	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	N223S	NONSYN	667	669	AAC	985	987	AGT	329;331;339	A;G;T	316;315;317	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1054	1056	CCG	476;476;482	C;C;G	428;426;430	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1156	1158	TCG	541;544;544	T;C;G,A	501;502;501,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1327	1329	AAA	274;273;264	A;A;A	260;261;250	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1330	1332	AAG	260;260;256	A;A;G	251;251;243	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1345	1347	CAC	213;215;214	C,T;A,C;C	208,1;200,1;211	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1384	1386	GAA	211;211;210	G;A;A	209;210;209	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1462	1464	ACG	162;161;161	A;C;G	160;159;158	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1513	1515	ATT	217;215;214	A;T;T	194;193;195	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1516	1518	AGT	216;216;215	A;G;T	197;197;195	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1555	1557	CTA	263;262;271	C;TAAAA,TAAA;A	248;249,1;254	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1597	1599	AAT	200;201;204	A;A;T	189;190;193	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1666	1668	TCA	290;292;293	T;C;A	275;277;274	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1690	1692	ATG	298;298;298	A;T;G	281;283;282	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	1984	1986	ACC	579;578;578	A;C;C	526;531;522	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10188	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2539	400.0	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2080	2082	GAA	600;602;603	G,C;A;A	533,1;534;535	.	Tetracycline resistance
